Publications

  1. Barreto JN, Ice LL, Thompson CA, Tosh PK, Osmon DR, Dierkhising RA, Plevak MF, Limper AH. Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy. Am J Hematol 2016 Nov; 91 (11):1113-1117 Epub 2016 Aug 22
    View PubMed
  2. Durani U, Dioverti Prono MV, Tosh PK, Patnaik M, Barreto JN, Tande AJ. Influenza infection in neutropenic adults. Infect Dis (Lond) 2016 Sep 16; 1-6 Epub 2016 Sept 16
    View PubMed
  3. Ice LL, Barreto JN, Dao BD, Wolf RC, Dierkhising RA, Jannetto PJ, Langman LJ, Tosh PK. Relationship of Sulfamethoxazole Therapeutic Drug Monitoring to Clinical Efficacy and Toxicity: A Retrospective Cohort Study. Ther Drug Monit 2016 Jun; 38 (3):319-26
    View PubMed
  4. Barreto JN, Ice LL, Thompson CA, Tosh PK, Osmon DR, Dierkhising RA, Plevak MF, Limper AH. Low incidence of pneumocystis pneumonia utilizing PCR-based diagnosis in patients with B-cell lymphoma receiving rituximab-containing combination chemotherapy American Journal of Hematology 2016; 91 (11):1113-7
  5. DeVries A, Talley P, Sweet K, Kline S, Stinchfield P, Tosh P, Danila R. Development and Implementation of the Ebola Traveler Monitoring Program and Clinical Outcomes of Monitored Travelers during October - May 2015, Minnesota. PLoS One 2016; 11 (12):e0166797 Epub 2016 Dec 01
    View PubMed
  6. Durani U, Tosh PK, Barreto JN, Estes LL, Jannetto PJ, Tande AJ. Retrospective Comparison of Posaconazole Levels in Patients Taking the Delayed-Release Tablet versus the Oral Suspension. Antimicrob Agents Chemother 2015 Aug; 59 (8):4914-8 Epub 2015 June 08
    View PubMed
  7. Ofstead CL, Wetzler HP, Doyle EM, Rocco CK, Visrodia KH, Baron TH, Tosh PK. Persistent contamination on colonoscopes and gastroscopes detected by biologic cultures and rapid indicators despite reprocessing performed in accordance with guidelines. Am J Infect Control 2015 Aug; 43 (8):794-801
    View PubMed
  8. Kennedy RB, Tosh PK, Goergen KM, Grill DE, Oberg AL, Poland GA. Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults. Vaccine 2015 Jul 17; 33 (31):3682-8 Epub 2015 June 16
    View PubMed
  9. Daniels LM, Barreto JN, Kuth JC, Anderson JR, Zhang B, Majka AJ, Morgenthaler TI, Tosh PK. Failure mode and effects analysis to reduce risk of anticoagulation levels above the target range during concurrent antimicrobial therapy. Am J Health Syst Pharm 2015 Jul 15; 72 (14):1195-203
    View PubMed
  10. Vasoo S, Barreto JN, Tosh PK. Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician. Mayo Clin Proc. 2015 Mar; 90(3):395-403.
    View PubMed
  11. Jacobson RM, Grill DE, Oberg AL, Tosh PK, Ovsyannikova IG, Poland GA. Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers. Hum Vaccin Immunother 2015; 11 (4):961-9
    View PubMed
  12. de Cogain MR, Lieske JC, Vrtiska TJ, Tosh PK, Krambeck AE. Secondarily infected nonstruvite urolithiasis: a prospective evaluation. Urology 2014 Dec; 84 (6):1295-300 Epub 2014 Oct 11
    View PubMed
  13. Tosh PK, Sampathkumar P. What clinicians should know about the 2014 Ebola outbreak. Mayo Clin Proc. 2014 Dec; 89(12):1710-7. Epub 2014 Oct 30.
    View PubMed
  14. Dao BD, Barreto JN, Wolf RC, Dierkhising RA, Plevak MF, Tosh PK. Serum peak sulfamethoxazole concentrations demonstrate difficulty in achieving a target range: a retrospective cohort study. Curr Ther Res Clin Exp. 2014 Dec; 76:104-9. Epub 2014 Nov 11.
    View PubMed
  15. Albrecht VS, Zervos MJ, Kaye KS, Tosh PK, Arshad S, Hayakawa K, Kallen AJ, McDougal LK, Limbago BM, Guh AY. Prevalence of and Risk Factors for Vancomycin-Resistant Staphylococcus aureus Precursor Organisms in Southeastern Michigan. Infect Control Hosp Epidemiol. 2014 Dec; 35(12):1531-4.
    View PubMed
  16. Einav S, Hick JL, Hanfling D, Erstad BL, Toner ES, Branson RD, Kanter RK, Kissoon N, Dichter JR, Devereaux AV, Christian MD, Task Force for Mass Critical Care. Surge capacity logistics: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e17S-43S.
    View PubMed
  17. Hick JL, Einav S, Hanfling D, Kissoon N, Dichter JR, Devereaux AV, Christian MD, Task Force for Mass Critical Care. Surge capacity principles: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e1S-e16S.
    View PubMed
  18. Dries D, Reed MJ, Kissoon N, Christian MD, Dichter JR, Devereaux AV, Upperman JS, Task Force for Mass Critical Care. Special populations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e75S-86S.
    View PubMed
  19. Dichter JR, Kanter RK, Dries D, Luyckx V, Lim ML, Wilgis J, Anderson MR, Sarani B, Hupert N, Mutter R, Devereaux AV, Christian MD, Kissoon N, Task Force for Mass Critical Care. System-level planning, coordination, and communication: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e87S-e102S.
    View PubMed
  20. Christian MD, Sprung CL, King MA, Dichter JR, Kissoon N, Devereaux AV, Gomersall CD, Task Force for Mass Critical Care. Triage: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e61S-74S.
    View PubMed
  21. Geiling J, Burkle FM Jr, West TE, Uyeki TM, Amundson D, Dominguez-Cherit G, Gomersall CD, Lim ML, Luyckx V, Sarani B, Christian MD, Devereaux AV, Dichter JR, Kissoon N, Task Force for Mass Critical Care. Resource-poor settings: response, recovery, and research: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e168S-77S.
    View PubMed
  22. Tosh PK, Feldman H, Christian MD, Devereaux AV, Kissoon N, Dichter JR, Task Force for Mass Critical Care, Task Force for Mass Critical Care. Business and continuity of operations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e103S-17S.
    View PubMed
  23. Devereaux AV, Tosh PK, Hick JL, Hanfling D, Geiling J, Reed MJ, Uyeki TM, Shah UA, Fagbuyi DB, Skippen P, Dichter JR, Kissoon N, Christian MD, Upperman JS, Task Force for Mass Critical Care, Task Force for Mass Critical Care. Engagement and education: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e118S-33S.
    View PubMed
  24. Ornelas J, Dichter JR, Devereaux AV, Kissoon N, Livinski A, Christian MD, Task Force for Mass Critical Care. Methodology: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):35S-41S.
    View PubMed
  25. Christian MD, Devereaux AV, Dichter JR, Rubinson L, Kissoon N, Task Force for Mass Critical Care. Introduction and executive summary: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):8S-34S.
    View PubMed
  26. Courtney B, Hodge JG Jr, Toner ES, Roxland BE, Penn MS, Devereaux AV, Dichter JR, Kissoon N, Christian MD, Powell T, Task Force for Mass Critical Care. Legal preparedness: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e134S-44S.
    View PubMed
  27. Biddison LD, Berkowitz KA, Courtney B, De Jong CM, Devereaux AV, Kissoon N, Roxland BE, Sprung CL, Dichter JR, Christian MD, Powell T, Task Force for Mass Critical Care. Ethical considerations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e145S-55S.
    View PubMed
  28. King MA, Niven AS, Beninati W, Fang R, Einav S, Rubinson L, Kissoon N, Devereaux AV, Christian MD, Grissom CK, Task Force for Mass Critical Care. Evacuation of the ICU: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement. Chest. 2014 Oct; 146(4 Suppl):e44S-60S.
    View PubMed
  29. Ramanan P, Barreto JN, Osmon DR, Tosh PK. Rothia bacteremia: a 10-year experience at Mayo Clinic, Rochester, Minnesota. J Clin Microbiol. 2014 Sep; 52(9):3184-9. Epub 2014 Jun 20.
    View PubMed
  30. Nagpal A, Wentink JE, Berbari EF, Aronhalt KC, Wright AJ, Krageschmidt DA, Wengenack NL, Thompson RL, Tosh PK. A cluster of Mycobacterium wolinskyi surgical site infections at an academic medical center. Infect Control Hosp Epidemiol 2014 Sep; 35 (9):1169-75
    View PubMed
  31. Visrodia KH, Ofstead CL, Yellin HL, Wetzler HP, Tosh PK, Baron TH. The use of rapid indicators for the detection of organic residues on clinically used gastrointestinal endoscopes with and without visually apparent debris. Infect Control Hosp Epidemiol. 2014 Aug; 35(8):987-94. Epub 2014 Jun 20.
    View PubMed
  32. Tosh PK, Bundrick JB. Clinical pearls in infectious diseases. Dis Mon. 2014 Jul; 60(7):394-401. Epub 2014 May 29.
    View PubMed
  33. Wojenski DJ, Barreto JN, Wolf RC, Tosh PK. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series. Clin Ther 2014 Jun 1; 36 (6):976-81 Epub 2014 May 13
    View PubMed
  34. Vasoo S, Madigan T, Cunningham SA, Mandrekar JN, Porter SB, Johnston B, Sampathkumar P, Tosh PK, Johnson JR, Patel R, Banerjee R. Prevalence of rectal colonization with multidrug-resistant Enterobacteriaceae among international patients hospitalized at Mayo Clinic, Rochester, Minnesota. Infect Control Hosp Epidemiol 2014 Feb; 35 (2):182-6
    View PubMed
  35. Zheteyeva YA, Tosh P, Patel PR, Martinez D, Kilborn C, Awosika-Olumo D, Khuwaja S, Ibrahim S, Ryder A, Tohme RA, Khudyakov Y, Thai H, Drobeniuc J, Heseltine G, Guh AY. Hepatitis B outbreak associated with a home health care agency serving multiple assisted living facilities in Texas, 2008-2010. Am J Infect Control. 2014 Jan; 42(1):77-81. Epub 2013 Oct 29.
    View PubMed
  36. Khanna S, Tosh PK. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc. 2014 Jan; 89(1):107-14.
    View PubMed
  37. Abidi MZ, Coelho-Prabhu N, Hargreaves J, Weiland T, Van Dyken I, Tande A, Tosh PK, Walker RC, Cummins NW. Mucormycosis in patients with inflammatory bowel disease: case series and review of the literature. Case Rep Med. 2014; 2014:637492. Epub 2014 Apr 27
    View PubMed
  38. Dirlam Langlay AM, Ofstead CL, Mueller NJ, Tosh PK, Baron TH, Wetzler HP. Reported gastrointestinal endoscope reprocessing lapses: the tip of the iceberg. Am J Infect Control. 2013 Dec; 41(12):1188-94. Epub 2013 Sep 08.
    View PubMed
  39. Tosh PK, Agolory S, Strong BL, Verlee K, Finks J, Hayakawa K, Chopra T, Kaye KS, Gilpin N, Carpenter CF, Haque NZ, Lamarato LE, Zervos MJ, Albrecht VS, McAllister SK, Limbago B, Maccannell DR, McDougal LK, Kallen AJ, Guh AY. Prevalence and risk factors associated with vancomycin-resistant Staphylococcus aureus precursor organism colonization among patients with chronic lower-extremity wounds in Southeastern Michigan. Infect Control Hosp Epidemiol. 2013 Sep; 34(9):954-60. Epub 2013 Jul 26.
    View PubMed
  40. Ofstead CL, Dirlam Langlay AM, Mueller NJ, Tosh PK, Wetzler HP. Re-evaluating endoscopy-associated infection risk estimates and their implications. Am J Infect Control. 2013 Aug; 41(8):734-6. Epub 2013 Jan 11.
    View PubMed
  41. Barreto JN, Beach CL, Wolf RC, Merten JA, Tosh PK, Wilson JW, Hogan WJ, Litzow MR. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole. Am J Hematol. 2013 Apr; 88(4):283-8. Epub 2013 Mar 05.
    View PubMed
  42. Cawcutt K, Tosh P, Elmer J, Copeman S, Rivera C. Pulmonary case of the month: a hidden connection. Southwest J Pulm Crit Care. 2013; 7(4). Epub 2013 Oct 1
  43. Tosh PK, Bulens SN, Nadle J, Dumyati G, Lynfield R, Schaffner W, Ray SM, Jain S, Fridkin SK, Sievert DM. Characterization of hospitalized community-onset staphylococcus aureus lower respiratory tract infections among generally healthy persons 50 years of age or younger. IDCP. 2013; 21(6):359-65.
  44. Tosh PK, McDonald LC. Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis. 2012 Mar 1; 54(5):707-13. Epub 2011 Dec 12.
    View PubMed
  45. Tosh PK, Disbot M, Duffy JM, Boom ML, Heseltine G, Srinivasan A, Gould CV, Berrios-Torres SI. Outbreak of Pseudomonas aeruginosa surgical site infections after arthroscopic procedures: Texas, 2009. Infect Control Hosp Epidemiol. 2011 Dec; 32(12):1179-86. Epub 2011 Oct 17.
    View PubMed
  46. Tosh PK, Jacobson RM, Poland GA. Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc. 2010 Mar; 85(3):257-73. Epub 2010 Jan 29.
    View PubMed
  47. Tosh PK, Kennedy RB, Vierkant RA, Jacobson RM, Poland GA. Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity. Viral Immunol 2009 Dec; 22 (6):451-6
    View PubMed
  48. Tosh PK, Poland GA. Emerging vaccines for influenza. Expert Opin Emerg Drugs. 2008 Mar; 13(1):21-40.
    View PubMed
  49. Tosh PK, Boyce TG, Poland GA. Flu myths: dispelling the myths associated with live attenuated influenza vaccine. Mayo Clin Proc. 2008 Jan; 83(1):77-84.
    View PubMed
  50. Tosh PK, Jacobson RM, Poland-Gregory A. Mandatory influenza vaccination for health care workers--a timely step forward. Md Med. 2006 Winter; 7(1):21-3.
    View PubMed
  51. Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine. 2005 Mar 18; 23(17-18):2251-5.
    View PubMed